Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Lung Neoplasms 4Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Depression 2Vulvar Neoplasms 1Vomiting 1Stomach Neoplasms 1Patient Compliance 1Pancreatic Neoplasms 1Non-resectable Metastatic Cancer of the Lung 1Neuroblastoma 1Nausea 1Leukemia 1Laryngeal Diseases 1Hematologic Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anxiety Disorders 1Anus Neoplasms 1

Interventions

durvalumab 2Radiotherapy 2tremelimumab 1rocakinogene sifuplasmid 1antineoplaston AS 2-1 1antineoplaston A10 1VGX-3100 1Surveys and Questionnaires 1Palliative Care 1Multimodal Imaging 1MEDI0457 1Interviews as Topic 1Immunoglobulin G 1Disulfides 1Device Removal 1Cisplatin 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Vulvar Neoplasms × Interviews as Topic × Clear all
NCT00394602 2020-01-02

Chemoradiation-Induced Nausea and Emesis: Quality of Life

M.D. Anderson Cancer Center

Terminated
207 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Nausea, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡